Harbin Medisan Pharmaceutical Co., Ltd. (SHE:002900)
China · Delayed Price · Currency is CNY 9.97
-0.32 (-3.11%)
Nov 13, 2026, 3:04 PM CST
SHE:002900 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Equivalents | 337.76 | 460.86 | 794.07 | 991.16 | 1,203 | 529.83 |
Trading Asset Securities | 44.59 | 150.78 | 48.08 | 57.75 | 91.25 | 581.68 |
Cash & Short-Term Investments | 382.35 | 611.64 | 842.15 | 1,049 | 1,294 | 1,112 |
Cash Growth | -47.98% | -27.37% | -19.71% | -18.93% | 16.41% | 8.73% |
Accounts Receivable | 93.97 | 83.1 | 221.19 | 99.46 | 124.6 | 132.98 |
Other Receivables | 3.53 | 4.57 | 13.36 | 1.73 | 0.99 | 0.64 |
Receivables | 97.5 | 87.67 | 234.55 | 101.19 | 125.59 | 133.62 |
Inventory | 232.58 | 236.76 | 307.67 | 208.79 | 161.16 | 156.55 |
Other Current Assets | 48.03 | 60.39 | 87.59 | 77.54 | 43.01 | 25.51 |
Total Current Assets | 760.46 | 996.46 | 1,472 | 1,436 | 1,624 | 1,427 |
Property, Plant & Equipment | 1,426 | 1,497 | 1,402 | 1,082 | 882.45 | 925.35 |
Long-Term Investments | 710.76 | 713.2 | 711.73 | 708.99 | 646.87 | 604.5 |
Goodwill | 9.08 | 0.84 | 1.34 | 1.34 | 0.5 | 9.44 |
Other Intangible Assets | 149.5 | 131.76 | 112.95 | 113.37 | 61.1 | 62.5 |
Long-Term Deferred Tax Assets | 33.61 | 32.87 | 25.22 | 23.08 | 24.68 | 25.84 |
Long-Term Deferred Charges | 78.23 | 74.82 | 66.38 | 57.96 | 38.4 | 10.69 |
Other Long-Term Assets | 12.8 | 9.01 | 8.88 | 20.22 | - | - |
Total Assets | 3,180 | 3,455 | 3,800 | 3,443 | 3,278 | 3,066 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Accounts Payable | 245.81 | 219.8 | 323.48 | 182.13 | 120.84 | 105.16 |
Accrued Expenses | 9.21 | 31.72 | 39.68 | 78.79 | 99.3 | 107.57 |
Short-Term Debt | 557.2 | 771.23 | 575.96 | 275.27 | 220.22 | 270.28 |
Current Portion of Long-Term Debt | 206.17 | 69.72 | 217.45 | 201.54 | 10.17 | 0.06 |
Current Portion of Leases | - | 1.41 | 3.35 | 3.42 | 3.4 | 4.46 |
Current Income Taxes Payable | 5.36 | - | 0.32 | 0.04 | 0.01 | 0.02 |
Current Unearned Revenue | 17.84 | 16.91 | 17.77 | 43.25 | 54.79 | 21.06 |
Other Current Liabilities | 61.25 | 34.81 | 79.72 | 60.61 | 89 | 27.99 |
Total Current Liabilities | 1,103 | 1,146 | 1,258 | 845.03 | 597.73 | 536.61 |
Long-Term Debt | 144.24 | 273.28 | 134.19 | 229.83 | 417.78 | 204.84 |
Long-Term Leases | 2.33 | 3.53 | 4.68 | 8.33 | 5.14 | 8.03 |
Long-Term Unearned Revenue | 111.11 | 126.35 | 103.91 | 79.03 | 83.86 | 88.96 |
Long-Term Deferred Tax Liabilities | 132.44 | 131.79 | 135.8 | 132.54 | 120.95 | 110.61 |
Total Liabilities | 1,501 | 1,681 | 1,636 | 1,295 | 1,225 | 949.04 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Common Stock | 316.35 | 316.35 | 316.36 | 316.39 | 316.6 | 316.6 |
Additional Paid-In Capital | 1,093 | 1,093 | 1,090 | 1,082 | 1,043 | 1,073 |
Retained Earnings | 269.45 | 363.74 | 766.64 | 771.23 | 729.21 | 797.94 |
Treasury Stock | - | - | -13.14 | -29.54 | -47.79 | -85.77 |
Total Common Equity | 1,679 | 1,773 | 2,160 | 2,140 | 2,041 | 2,101 |
Minority Interest | 0.61 | 2.09 | 4.03 | 7.73 | 11.32 | 15.02 |
Shareholders' Equity | 1,679 | 1,775 | 2,164 | 2,148 | 2,052 | 2,116 |
Total Liabilities & Equity | 3,180 | 3,455 | 3,800 | 3,443 | 3,278 | 3,066 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Total Debt | 909.94 | 1,119 | 935.63 | 718.38 | 656.73 | 487.67 |
Net Cash (Debt) | -527.59 | -507.54 | -93.47 | 330.54 | 637.17 | 623.84 |
Net Cash Growth | - | - | - | -48.12% | 2.14% | -17.09% |
Net Cash Per Share | -1.67 | -1.60 | -0.30 | 1.08 | 2.11 | 2.01 |
Filing Date Shares Outstanding | 316.35 | 316.36 | 298.74 | 278.39 | 309.78 | 309.78 |
Total Common Shares Outstanding | 316.35 | 316.36 | 298.74 | 278.39 | 309.78 | 309.78 |
Working Capital | -342.38 | -149.15 | 214.23 | 591.4 | 1,026 | 890.58 |
Book Value Per Share | 5.31 | 5.60 | 7.23 | 7.69 | 6.59 | 6.78 |
Tangible Book Value | 1,520 | 1,640 | 2,046 | 2,026 | 1,979 | 2,030 |
Tangible Book Value Per Share | 4.80 | 5.18 | 6.85 | 7.28 | 6.39 | 6.55 |
Buildings | - | 995.93 | 912.24 | 644.88 | 635.65 | 640.66 |
Machinery | - | 1,202 | 1,057 | 799.09 | 737.21 | 716.18 |
Construction In Progress | - | 141.94 | 162.84 | 269.26 | 58.34 | 45.31 |